OCRHIPAA Security Rule

HIPAA Transmission Security Standard (45 CFR 164.312(e))

Required standard to guard against unauthorized access to ePHI transmitted over an electronic communications network, with addressable specs for integrity controls and encryption.

Primary source

45 CFR 164.312(e) — eCFR

https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-C/part-164/subpart-C/section-164.312#p-164.312(e)

Verified May 23, 2026 · This is the authoritative regulator URL. The summary below is a research aid; the linked source controls.

45 CFR 164.312(e)) requires technical security measures to guard against unauthorized access to ePHI being transmitted over an electronic communications network.

Two addressable specifications: integrity controls (security measures to ensure that ePHI is not improperly modified without detection until disposed of); and encryption (a mechanism to encrypt ePHI whenever deemed appropriate).

Addressable does not mean optional. The risk analysis must justify whether each spec is reasonable. For ePHI traversing the public internet, the defensible answer to encryption is yes — TLS 1.2 or higher with current cipher suites, evolving as protocols deprecate (TLS 1.0/1.1 are no longer acceptable). End-to-end encryption (S/MIME or similar) for email containing PHI is the cleaner posture; opportunistic TLS at the SMTP gateway is the practical minimum.

OCR's encryption Safe Harbor in the Breach Notification Rule at 164.402 means properly encrypted ePHI lost in transit is not subject to breach notification — an outsized business and operational benefit that pulls many practices to encrypt by default.

Use this in your workspace

D3rx assembles the documentation linked to this regulation, walks the practical decisions in plain English, and stores the artifacts against the .gov sources cited above. It is an administrative research aid, not a substitute for counsel.

Related regulations

Authored by D3rx

D3rx is a healthcare-billing and compliance research aid maintained by D3rx Inc. Articles are drafted by an LLM (Anthropic Claude) against primary HHS, OCR, CMS, eCFR, NIST, and state-regulator publications, and reviewed for restraint and source fidelity by the D3rx team.

Reviewer status: a named credentialed reviewer (CHC, CHPC, or healthcare attorney) is being engaged. Until that engagement is finalized, this page does not claim credentialed review.

Last reviewed May 23, 2026 · Citation verified May 23, 2026

Research aid, not legal advice. This summary is an administrative research aid prepared by D3rx. It does not certify compliance, provide legal advice, replace counsel, or guarantee an audit outcome. For authoritative regulatory text follow the primary source link at the top of this page. The practice remains responsible for reviewing, adopting, and maintaining its compliance program.